| 1 |
World Health Organization (WHO). Coronavirus disease (COVID-2019) situation reports. Available at https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Accessed on April 2, 2020.
|
| 2 |
Testa S, Paoletti O, Giorgi-Pierfranceschi M, Pan A. Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients. Intern Emerg Med. 2020 Apr. 15; 1-3.
doi: 10.1007/s11739-007-0001-6
pmid: 17551676
|
| 3 |
Marietta M, Ageno W, Artoni A, de Candia E, Gresele P, Marchetti M, et al. COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET). Blood Transfus. 2020; 18(3):167-9.
doi: 10.2450/2020.0083-20
pmid: 32281926
|
| 4 |
Whitlock RP, Sun JC, Fremes SE, Rubens FD, Teoh KH. Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141(2 Suppl):e576S-e600S.
doi: 10.1378/chest.11-2305
pmid: 22315272
|
| 5 |
Han H, Yang L, Liu R, Liu F, Wu KL, Li J, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020; 58(7):1116-20.
doi: 10.1515/cclm-2020-0188
pmid: 32172226
|
| 6 |
Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020; 191:145-7.
doi: 10.1016/j.thromres.2020.04.013
pmid: 32291094
|
| 7 |
Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020; 395(10229):1033-4.
doi: 10.1016/S0140-6736(20)30628-0
pmid: 32192578
|
| 8 |
Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020; 18(5):1094-9.
doi: 10.1111/jth.14817
pmid: 32220112
|
| 9 |
Spiezia L, Boscolo A, Poletto F, Cerruti L, Tiberio I, Campello E, et al. COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure. Thromb Haemost. 2020; 120(6):998-1000.
doi: 10.1055/s-0040-1710018
pmid: 32316063
|
| 10 |
Fanikos J, Tsilimingras K, Kucher N, Rosen AB, Hieblinger MD, Goldhaber SZ. Comparison of efficacy, safety, and cost of low-molecular-weight heparin with continuous-infusion unfractionated heparin for initiation of anticoagulation after mechanical prosthetic valve implantation. Am J Cardiol. 2004; 93(2):247-50.
doi: 10.1016/j.amjcard.2003.09.054
pmid: 14715362
|
), Sara Bernardi1, Giulia Paglietta2, Giulia Lucia Massimina Cavalot1, Luca Alessio Dutto1, Daniela Caruso1, Andrea Tortore1, Giuseppe Lauria1
